Literature DB >> 15151381

Controlling lead concentrations in human blood by regulating the use of lead in gasoline.

Hans von Storch1, Charlotte Hagner.   

Abstract

After having been emitted at maximum rates in the 1960s and 1970s, lead has become less ubiquitous in industrialized countries as a result of increasingly stringent policies to limit the use of this heavy metal as an anti-knock additive in gasoline. Using a detailed reconstruction of lead emissions in Europe (PbE), of the air concentration of lead in Europe (PbC) and repeated measurements of lead concentrations in human blood (PbB) in Germany since about 1980, we have constructed an empirical model that estimates PbB given PbE. This model is used for 2 purposes: i)To estimate PbB levels for the 1960s and 1970s in Germany, when emissions were maximum and monitoring blood levels had not yet begun. It turns out that PbB peak emissions were reaching a mean level, which health officials considered potentially harmful for fetuses and small children. ii) To estimate how PbB levels may have developed if regulations of the use of lead in gasoline had been implemented differently. In case of no or delayed regulations, the model estimates that PbB levels well beyond the critical level would have emerged. Thus, the regulation instituted in Germany since the 1970s has reduced significant health hazards.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151381

Source DB:  PubMed          Journal:  Ambio        ISSN: 0044-7447            Impact factor:   5.129


  2 in total

Review 1.  Impacts of lead/zinc mining and smelting on the environment and human health in China.

Authors:  Xiuwu Zhang; Linsheng Yang; Yonghua Li; Hairong Li; Wuyi Wang; Bixiong Ye
Journal:  Environ Monit Assess       Date:  2011-05-14       Impact factor: 2.513

2.  Influence of abatement of lead exposure in Croatia on blood lead and ALAD activity.

Authors:  Kljaković-Gašpić Zorana; Pizent Alica; Jurasović Jasna
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-09       Impact factor: 4.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.